Daiwa SMBC Capital - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $96,105.88 -0.94%
Ethereum $3,343.96 -1.46%
BNB $670.60 +0.40%
Optimism $1.81 -0.08%
Arbitrum $0.77 +0.33%
Solana $185.40 -0.57%
Polygon $0.48 -1.07%
Cosmos $6.56 -1.60%
Avalanche $37.29 -2.38%

Bitcoin $96,105.88 -0.94%
Ethereum $3,343.96 -1.46%
BNB $670.60 +0.40%
Optimism $1.81 -0.08%
Arbitrum $0.77 +0.33%
Solana $185.40 -0.57%
Polygon $0.48 -1.07%
Cosmos $6.56 -1.60%
Avalanche $37.29 -2.38%

Daiwa SMBC Capital

investment firm

Summary
Investments
Exits
Employees

About

Daiwa SMBC Capital is a venture capital firm that finances later stage and private equity investments.

Tokyo,Tokyo,Japan

Highlights

Lead Investments

Employee Profiles

Details

Operating Status: Active
Also Known As: 大和SMBCキャピタル
Investor Type: Venture Capital

Daiwa SMBC Capital is a venture capital firm based in Tokyo that finances later stage and private equity investments.

Investments

Number of Investments

Number of Lead Investments

7

2

Daiwa SMBC Capital has made 7 investments. Their most recent investment was on Feb 1, 2012, when REGiMMUNE raised $5M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Feb 1, 2012 REGiMMUNE	Series C	$5M	Biopharma	Yes
Jul 7, 2010 Gene Techno Science	Series Unknown	¥507.90M	Biopharma	—
Oct 15, 2008 100e.com	Series B	$8M	Cloud Computing	Yes
May 15, 2007 NexWave Solutions	Series C	$5M	Consumer Electronics	—
Feb 12, 2007 Picsel Technologies	Series C	$46.50M	Embedded Software	—

Show More

Employee Profiles

Number of Employee Profiles

1

Daiwa SMBC Capital has 1 current employee profiles, including Executive Kawasaki Kenichi

Kawasaki Kenichi

Executive

Exits

Daiwa SMBC Capital has had 3 exits. Daiwa SMBC Capital most notable exits include FibroGen , Gene Techno Science

Date	Company Name	Exit Type	Industry
Nov 21, 2014	FibroGen	IPO	Biopharma	Detail
Nov 30, 2012	Gene Techno Science	M&A	Biopharma	Detail
May 17, 2011	SiGe Semiconductor	M&A	Consumer Electronics	Detail